Literature DB >> 11297080

Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report.

M Papós1, A Pekrun, J W Herms, T M Behr, J Meller, H H Rustenbeck, H A Kretzschmar, W Becker.   

Abstract

A 10-year-old girl presented with a cerebral malignant ectomesenchymoma (MEM), a very unusual tumour with undifferentiated mesenchymal as well as ectodermal elements. Somatostatin receptor scintigraphy (SRS) was performed during the diagnostic workup. The recurrent residual tumour mass was exactly visualized with SRS, and was negative after successful treatment of the patient. The potential application of SRS in initial staging, follow-up and therapy planning in MEM is discussed. This is the first application of SRS in MEM.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11297080     DOI： 10.1007/s002470000404

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  3 in total

1.  Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma.

Authors:  Shih-Chiang Huang; Rita Alaggio; Yun-Shao Sung; Chun-Liang Chen; Lei Zhang; Yu-Chien Kao; Narasimhan P Agaram; Leonard H Wexler; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-07       Impact factor: 6.394

Review 2.  Malignant ectomesenchymoma of the cerebrum. Case report and discussion of therapeutic options.

Authors:  Elisabeth Weiss; Clemens F Albrecht; Jochen Herms; Julianne Behnke-Mursch; Arnulf Pekrun; Knut Brockmann; Clemens F Hess
Journal:  Eur J Pediatr       Date:  2005-03-04       Impact factor: 3.183

3.  Metastatic malignant ectomesenchymoma initially presenting as a pelvic mass: report of a case and review of literature.

Authors:  A Nael; P Siaghani; W W Wu; K Nael; Lisa Shane; S G Romansky
Journal:  Case Rep Pediatr       Date:  2014-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.